| First Author | Rezaeian AH | Year | 2020 |
| Journal | Cancer Res | Volume | 80 |
| Issue | 2 | Pages | 139-150 |
| PubMed ID | 31767626 | Mgi Jnum | J:283702 |
| Mgi Id | MGI:6386923 | Doi | 10.1158/0008-5472.CAN-19-1807 |
| Citation | Rezaeian AH, et al. (2020) Therapeutic Potential of the miRNA-ATM Axis in the Management of Tumor Radioresistance. Cancer Res 80(2):139-150 |
| abstractText | The ataxia-telangiectasia mutated (ATM) protein kinase is widely known for its function as a chief mobilizer of the DNA damage response (DDR) upon DNA double-strand breaks. ATM orchestrates the DDR by modulating the expression of various miRNAs through several mechanisms. On the other hand, a set of miRNAs contribute to tight regulation of ATM by directly targeting the 3'-untranslated region of ATM mRNA. This review addresses the therapeutic application and molecular mechanisms that underlie the intricate interactions between miRNAs and ATM. It also describes therapeutic delivery of miRNAs in different environments such as hypoxic tumor microenvironments. |
